119th Congress
S. 5571
Biosimilars Access and Affordability Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Marsha Blackburn(R-TN)
- Introduced
- Sep 28, 2026
- Policy area
- Health
- Committees
- Senate Committee on Finance
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (3)
Original cosponsors (3)
- Adam B. Schiff (D-CA)
- James Lankford (R-OK)
- Ted Budd (R-NC)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Latest action(Sep 28, 2026): Read twice and referred to the Committee on Finance.
Roll-call votes
No recorded votes on this bill.
Actions
- Sep 28, 2026 · Senate
Read twice and referred to the Committee on Finance. - Sep 28, 2026
Introduced in Senate